new york  reuters    u s  president elect donald trump on wednesday said pharmaceutical companies are  getting away with murder  in what they charge the government for medicines  and promised that would change  sending drugs stocks sharply lower  the benchmark s p  index  spx slipped into negative territory after his remarks at a news conference spooked investors  the ishares nasdaq biotech etf  ibb o  dropped  percent at its session low and ended down  percent  its largest daily percentage drop in three months   when the president elect says we re going to negotiate drug pricing  you have to take that seriously  but at the same this is a complicated issue because there s not going to be clarity on drug pricing reform anytime soon   said brad loncar  manager of the loncar cancer immunotherapy etf  cncr o    when somebody that high profile says something that negative  people do not want to invest in it   trump has blasted other industries for charging the government too much  particularly defense companies  but has made only a few public statements about drug pricing since being elected  he briefly mentioned lockheed martin corp  lmt n   ford motor co  f n   and united technologies corp  utx n  during the news conference and promised a border tax for companies producing products for u s  consumers outside the united states  back in may  then candidate trump said amazon  amzn o  was also  getting away with murder   referring to taxes in that case  the stock fell as much as  percent in the next few days but is up almost  percent since trump s remark  after his promise to bring down drug spending  the arca pharmaceutical index gave up as much as   percent and ended the day down   percent  the drug industry has been on edge for two years about the potential for more government pressure on pricing after sharp increases in the costs of some life saving drugs drew scrutiny in the press and among lawmakers  the government is investigating medicaid and medicare overspending on mylan nv s  myl o  allergy treatment epipen  for instance  david katz  chief investment officer at matrix asset advisors in new york  said negative comments on drug pricing trigger selling both from algorithms and investors who suffered from share drops when democrat hillary clinton campaigned against healthcare cost increases  trump s campaign platform included allowing the medicare healthcare program to negotiate with pharmaceutical companies  which the law currently prohibits  he has also discussed making it easier to import drugs at cheaper prices   we are going to start bidding  we are going to save billions of dollars over time   trump said  medicare  which covers more than  million elderly or disabled americans  spent   billion on medicines in   industry trade group pharmaceutical research and manufacturers of america  or phrma president stephen ubl said  medicines are purchased in a competitive marketplace where large  sophisticated purchasers aggressively negotiate lower prices    he said the industry is  committed to working with president elect trump and congress to improve american competitiveness and protect american jobs    roche pharmaceuticals ceo daniel o day said in an interview at a jpmorgan conference in san francisco that roche holding ag  rog s  focuses on innovation and investing in research  price increases over the past several years have been  responsible  and in the range of low to mid single digits  he said  at the same conference  mylan ceo heather bresch said it was premature to respond to trump s comments  when she was asked during an investor presentation  she said the industry should look again at how healthcare is set up as the government repeals the affordable care act   trump said he plans to repeal the affordable care act  or obamacare  and replace it at about the same time  the news helped shares of hospitals  which are nervous about losing government payments for medical services  it hurt some health insurers  like anthem inc  antm n   which sell plans on the government run health insurance exchanges  healthcare etfs including the health care select sector spdr fund  xlv   xlv p  and the ibb drew their highest trading volume since nov    in the wake of trump s election  trading volume in xlv options jumped to   contracts  more than twice the average daily volume according to reuters data  healthcare sector stocks were the largest drag on the s p   spx and the nasdaq   ndx  